A New Survey of U.S. Psychiatrists Suggests that Some Psychoactive Drugs Need to be Reclassified by the DEA
A new survey shows a significant difference between U.S. policies on drugs versus how psychiatrists view their safety, which could eventually lead to a push for new classifications in the years ahead.Â